C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2007
10/24/2007	EP1846024A2 Mycobacterial mutants affecting host apoptosis
10/24/2007	EP1846023A2 A plasmodium vivax hybrid circumsporozoite protein and vaccine
10/24/2007	EP1311281B1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
10/24/2007	EP1233982B1 Novel hcv non-structural polypeptide
10/24/2007	EP1064359B1 Phenol oxidizing enzyme enzymes
10/24/2007	EP0723588B1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
10/24/2007	CN101061231A Production of TNFR-Ig fusion protein
10/24/2007	CN101061225A Methods and compositions for concentrating secreted recombinant protein
10/24/2007	CN101061215A Cell culture method and utilization of the same
10/24/2007	CN101060855A Gastrointestinal proliferative factor and uses thereof
10/24/2007	CN101058832A Method for detecting growth hormone variations in humans, the variations and their uses
10/24/2007	CN101058822A Method of extracting rice bran polysaccharide and rice bran protein
10/24/2007	CN101058807A Optimized monoclonal antibody
10/24/2007	CN101058805A Method of producing mutation procarboxypeptidase B and mutation carboxypeptidase B
10/24/2007	CN101058600A Oxidation resistance zymolyte rich in pollen active peptide
10/24/2007	CN100344970C Treatment and diagnosis of cancer
10/24/2007	CN100344765C DNA sequences for regulating transcription
10/24/2007	CN100344758C Antibacterial peptide gene of Chinese prawn containing single whey acidic protein structure domain and its coded antibacterial peptide and application
10/24/2007	CN100344650C Cytoplasm film marked compound and its preparation method
10/24/2007	CN100344649C Mermaid luminous bacillus outer membrane protein V and coding sequence, its preparation method and application
10/23/2007	US7285654 Stimulus-inducible protein kinase complex and methods of use therefor
10/23/2007	US7285651 Ourifying supercoiled vector DNA from cell lysate via crystallized calcium silicate adsorption; DNA extraction
10/23/2007	US7285650 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy
10/23/2007	US7285645 PRO4356 antibodies
10/23/2007	US7285644 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2007	US7285641 Antibodies against gene products related to Werner's Syndrome
10/23/2007	US7285639 Antibody to telomerase reverse transcriptase
10/23/2007	US7285636 Vectors with DNA encoding pro polypeptides
10/23/2007	US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity
10/23/2007	US7285631 Forsenic analysis; medical diagnosis; chromosome markers
10/23/2007	US7285630 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor
10/23/2007	US7285628 PRO1867 polypeptides
10/23/2007	US7285627 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
10/23/2007	US7285623 Novel DNA and to the recombinant production of novel polypeptides encoded by that DNA
10/23/2007	US7285537 Oligonucleotide therapeutic agent and methods of making same
10/23/2007	US7285535 Administering TIRAP to block Toll/Interleukin-1 Receptor Adaptor Protein signaling in a cell; for treatment of inflammation and inducing or affecting immune response.
10/23/2007	US7285407 Genes of cell wall-degrading enzymes derived from aspergillus, and method for the production the enzymes
10/23/2007	US7285406 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from Comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids
10/23/2007	US7285404 High anthelmintic activity against animal parasitic nematodes
10/23/2007	US7285400 High bone mass gene of 11q13.3
10/23/2007	US7285399 Compositions and methods using the yeast YMR107W promoter
10/23/2007	US7285397 Gene expressing wasp poison allergen antigen 5 in bacteria in an insoluble form as inclusion bodies; denaturing using guanidine chloride without any reducing agent, and dialysis against acidic buffer; immunotherapy; genetic engineering
10/23/2007	US7285390 Screening methods for identifying compounds which decrease HIV entry into a cell
10/23/2007	US7285389 Protein, gene encoding the same, and method of utilization thereof
10/23/2007	US7285386 Animal modeling human papillomavirus infection in a Rhesus macaque by contacting anogenital and/or cervical tissue or respiratory epithelial tissue with infectious Rhesus papillomavirus (RhPV) virions; evaluating for symptoms and/or viral replication
10/23/2007	US7285382 Compositions and methods for treatment of cancer
10/23/2007	US7285381 Insertion in amino acid sequence of structural protein; purification, mutagenesis, genetic engineering; higher titers; gene therapy, cell transformation
10/23/2007	US7285379 Complex of albumin and porphyrin; mixing under inert gas albumin and porphyrin
10/23/2007	US7285281 Genetically engineered toxin comprising a-subunit of wildtype cholera toxin for treatment and prevention of infections, cell proliferative, nervous system and metabolic disorders
10/23/2007	US7285276 Polynucleotide sequence for Chlamydia pneumonia; therapy, prevention of Chlamydia infections
10/23/2007	US7285275 Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor
10/23/2007	US7285273 Administering an immunogenically effective amount of TH epitope-containing IL5 polypeptide wherein TH epitope-containing IL5 polypeptide differs from the animal's autologous IL5 polypeptide in that the TH epitope-containing IL5 polypeptide comprises at least one foreign TH epitope
10/23/2007	CA2391098C Recombinant .alpha.-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/23/2007	CA2341946C Polypetides and compositions prepared from the amplification of the hiv-2 and siv-type retrovirus genome,
10/23/2007	CA2271697C Tissue type plasminogen activator (t-pa) variants: compositions and methods of use
10/23/2007	CA2263889C P-selectin ligand proteins
10/23/2007	CA2216250C Casein phosphopeptide, casein containing same and process for the preparation thereof
10/23/2007	CA2149171C Recombinant yeast producing a decreased amount of hydrogen sulfide in beer production
10/23/2007	CA2111325C Detection of mammalian immunodeficiency viruses
10/23/2007	CA2086258C Pasteurella multocida toxoid vaccines
10/18/2007	WO2007116925A1 hCL-K1 POLYPEPTIDE HAVING COLLECTIN ACTIVITY
10/18/2007	WO2007115813A1 Glycosylated antibodies
10/18/2007	WO2007087384A3 Methods for modulating mannose content of recombinant proteins
10/18/2007	WO2007075438A3 Polypeptides comprising unnatural amino acids, methods for their production and uses therefor
10/18/2007	WO2006088951A9 Cd38 modulated chemotaxis
10/18/2007	US20070244303 comprising an Fc region derived from a human IgG heavy chain, wherein the Fc region lacks effector function; for the reduction of a deleterious immune response; idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia
10/18/2007	US20070244302 Antibodies And Methods For Generating Genetically Altered Antibodies With High Affinity
10/18/2007	US20070244047 Albumin fusion proteins
10/18/2007	US20070244037 Human Chemokine HCC-1 Polypeptides To Improve Stem Cell Transplantation
10/18/2007	US20070244035 Novel co-modulators of nuclear receptors and methods of detecting and treating steroid hormone-dependent diseases using same
10/18/2007	US20070244020 Enzyme fusion proteins and their use
10/18/2007	US20070243589 Antibodies against human IL-22 and uses therefor
10/18/2007	US20070243588 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
10/18/2007	US20070243587 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
10/18/2007	US20070243585 Using expression vector comprising bacterial nucleotide sequences to prepare polypeptides for use in diagnosis, prevention and treatment of microorganismal infection
10/18/2007	US20070243584 Tetramerizing polypeptides and methods of use
10/18/2007	US20070243583 comprising an N-terminal domain derived from E. coli FkpA that allows for dimerization and provides a substrate binding region, and a C-terminal thioredoxin domain derived from E. coli DsbA
10/18/2007	US20070243582 Process for Producing Protein a-Like Protein with Use of Brevibacillus Genus Bacterium
10/18/2007	US20070243581 Process for Producing Dipeptides
10/18/2007	US20070243580 BASB019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
10/18/2007	US20070243569 producing a kinase/phosphatase inducible domain by replacing a structurally significant glutamic acid or aspartic acid residue in an EF hand domain with a replacement serine or threonine residue; producing a phosphorylation-dependent protein domain; Alzheimer's and heart disease
10/18/2007	US20070243564 Identification of Antibody-Producing Cells
10/18/2007	US20070243303 Methods and Means for Regulating Gene Expression
10/18/2007	US20070243235 Compositions and methods for producing fermentation products and residuals
10/18/2007	US20070243208 Novel chimeric protein for prevention and treatment of hiv infection
10/18/2007	US20070243205 Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
10/18/2007	US20070243202 Tumor necrosis factor receptor-associated factors
10/18/2007	US20070243194 Anti-IGF-1R antibodies and uses thereof
10/18/2007	US20070243193 Compositions and methods for the diagnosis and treatment of tumor
10/18/2007	US20070243176 Human genes and gene expression products
10/18/2007	CA2647524A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
10/18/2007	CA2647288A1 Glycosylated antibodies
10/18/2007	CA2638774A1 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
10/18/2007	CA2616859A1 Compositions and methods for production of immunoglobulins
10/17/2007	EP1845163A2 Adeno-associated virus serotype l nucleic acid sequences, vetors and host cells containing same
10/17/2007	EP1845108A2 Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
10/17/2007	EP1629102A4 Modified starch, uses, methods for production thereof
10/17/2007	EP1578372A4 Ca125 gene and its use for diagnostic and therapeutic interventions
10/17/2007	EP1427758B1 Compositions and methods of treating diabetes
10/17/2007	EP1294892B1 Assembly of wild-type and chimeric influenza virus-like particles (vlps)

1 ... 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 ... 1125